The 2nd Japan public-private dialogue forum-a multi-stakeholder dialogue on universal health coverage for cancer in Asia-seeking an approach to Asia health and wellbeing initiative

Hideyuki Akaza, Norie Kawahara, Hitoshi Nakagama, Yuukou Kitagawa, Tetsuo Noda

研究成果: Review article

抄録

On 5 September 2018 the UlCC-Asia Regional Office (UICC-ARO) convened the second Japan Public-Private Dialogue Forum at the House of Councilors Members' Building as a follow-up to the previous meeting held at United Nations University in Tokyo in April 2018. Senior representatives of government, academia and industry met to discuss the progress made since April, noting the significance of the Japanese government having included specific reference to cancer in its revised basic policy on the Asia Health and Wellbeing Initiative, which was adopted in July 2018. The meeting provided an opportunity for all stakeholders to discuss ways forward for improving access to cancer care, with the WHO Cancer Report and other global initiatives in mind.

元の言語English
ページ(範囲)655-671
ページ数17
ジャーナルJapanese Journal of Cancer and Chemotherapy
46
発行部数4
出版物ステータスPublished - 2019 4 1

Fingerprint

Universal Coverage
Japan
Health
Neoplasms
Tokyo
United Nations
Industry

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

これを引用

@article{567cf05503bc47b5927150c15402759d,
title = "The 2nd Japan public-private dialogue forum-a multi-stakeholder dialogue on universal health coverage for cancer in Asia-seeking an approach to Asia health and wellbeing initiative",
abstract = "On 5 September 2018 the UlCC-Asia Regional Office (UICC-ARO) convened the second Japan Public-Private Dialogue Forum at the House of Councilors Members' Building as a follow-up to the previous meeting held at United Nations University in Tokyo in April 2018. Senior representatives of government, academia and industry met to discuss the progress made since April, noting the significance of the Japanese government having included specific reference to cancer in its revised basic policy on the Asia Health and Wellbeing Initiative, which was adopted in July 2018. The meeting provided an opportunity for all stakeholders to discuss ways forward for improving access to cancer care, with the WHO Cancer Report and other global initiatives in mind.",
author = "Hideyuki Akaza and Norie Kawahara and Hitoshi Nakagama and Yuukou Kitagawa and Tetsuo Noda",
year = "2019",
month = "4",
day = "1",
language = "English",
volume = "46",
pages = "655--671",
journal = "Japanese Journal of Cancer and Chemotherapy",
issn = "0385-0684",
publisher = "Japanese Journal of Cancer and Chemotherapy Publishers Inc.",
number = "4",

}

TY - JOUR

T1 - The 2nd Japan public-private dialogue forum-a multi-stakeholder dialogue on universal health coverage for cancer in Asia-seeking an approach to Asia health and wellbeing initiative

AU - Akaza, Hideyuki

AU - Kawahara, Norie

AU - Nakagama, Hitoshi

AU - Kitagawa, Yuukou

AU - Noda, Tetsuo

PY - 2019/4/1

Y1 - 2019/4/1

N2 - On 5 September 2018 the UlCC-Asia Regional Office (UICC-ARO) convened the second Japan Public-Private Dialogue Forum at the House of Councilors Members' Building as a follow-up to the previous meeting held at United Nations University in Tokyo in April 2018. Senior representatives of government, academia and industry met to discuss the progress made since April, noting the significance of the Japanese government having included specific reference to cancer in its revised basic policy on the Asia Health and Wellbeing Initiative, which was adopted in July 2018. The meeting provided an opportunity for all stakeholders to discuss ways forward for improving access to cancer care, with the WHO Cancer Report and other global initiatives in mind.

AB - On 5 September 2018 the UlCC-Asia Regional Office (UICC-ARO) convened the second Japan Public-Private Dialogue Forum at the House of Councilors Members' Building as a follow-up to the previous meeting held at United Nations University in Tokyo in April 2018. Senior representatives of government, academia and industry met to discuss the progress made since April, noting the significance of the Japanese government having included specific reference to cancer in its revised basic policy on the Asia Health and Wellbeing Initiative, which was adopted in July 2018. The meeting provided an opportunity for all stakeholders to discuss ways forward for improving access to cancer care, with the WHO Cancer Report and other global initiatives in mind.

UR - http://www.scopus.com/inward/record.url?scp=85067493740&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85067493740&partnerID=8YFLogxK

M3 - Review article

C2 - 31164504

AN - SCOPUS:85067493740

VL - 46

SP - 655

EP - 671

JO - Japanese Journal of Cancer and Chemotherapy

JF - Japanese Journal of Cancer and Chemotherapy

SN - 0385-0684

IS - 4

ER -